藥物發現平台市場：按藥物類型、技術、治療領域、應用、最終用戶和地區分類。

預計到2026年，藥物發現平台市場規模將達到2.402億美元，到2033年將達到5.902億美元。預計從2026年到2033年，該市場將以13.7%的複合年成長率成長。

近年來，受新型療法需求成長和對更高效藥物研發流程的需求推動，全球藥物發現平台市場經歷了顯著成長。藥物發現平台在識別和開發新候選藥物方面發揮著至關重要的作用，它們利用高通量篩檢、基因組學、蛋白質組學和計算工具等先進技術。這些平台能夠幫助研究人員簡化藥物研發流程，降低成本，並縮短從初步篩檢到臨床試驗的時間。該市場涵蓋多種類型的平台，包括生化分析、細胞分析、In Silico模擬和基於片段的藥物研發。慢性病盛行率的上升、個人化醫療的興起以及製藥公司與學術機構之間合作的加強，進一步加速了藥物發現平台的應用。

市場動態：

全球藥物發現平台市場受多種因素驅動，包括慢性病盛行率的上升、對個人化醫療日益成長的需求以及對更高效藥物發現流程的需求。癌症、心血管疾病和神經系統疾病的盛行率上升，使得對新型療法的需求顯著增加，從而推動了藥物發現平台市場的成長。此外，向個人化醫療的轉變需要開發標靶治療，而藥物發現平台對於識別特定分子標靶和最佳化候選藥物至關重要。然而，藥物發現和開發的高成本以及嚴格的藥物核准監管要求，限制了市場成長。此外，熟練專業人員的短缺以及各種技術整合的複雜性也對市場成長構成挑戰。儘管有這些限制，市場仍蘊藏著巨大的機遇，包括人工智慧 (AI) 和機器學習在藥物發現領域的應用日益廣泛、對罕見疾病的關注度不斷提高，以及製藥公司與技術提供者在開發創新藥物發現解決方案方面的潛在合作。

本研究的主要特點：

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究根據以下參數對全球藥物發現平台市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份全球藥物發現平台市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過分析全球藥物發現平台市場時所使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 促進因素
• 抑制因子
• 機會
• 影響分析
• 主要進展
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球藥物發現平台市場：依藥物類型分類，2021-2033年

• 低分子
• 聚合物化合物

第5章 全球藥物發現平台市場：依技術分類，2021-2033年

• 基因組學
• 蛋白質體學
• 基於細胞的檢測
• 高通量篩檢（HTS）
• 生物資訊學
• 次世代定序（NGS）
• 質譜分析
• 成像技術
• 微流體技術
• 人工智慧（AI）和機器學習（ML）

第6章 全球藥物發現平台市場：依治療領域分類，2021-2033年

• 腫瘤學
• 神經病學
• 感染疾病及免疫系統疾病
• 消化器官系統疾病
• 心血管疾病
• 糖尿病
• 呼吸系統疾病

第7章 全球藥物發現平台市場：依應用領域分類，2021-2033年

• 目標識別
• 目標驗證
• 發現鉛
• 先導藥物最適化
• 臨床前試驗
• 其他（臨床試驗等）

第8章 全球藥物發現平台市場：依最終用戶分類，2021-2033年

• 生物製藥公司
• 學術研究機構
• CRO/CDMO
• 其他

第9章 全球藥物發現平台市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第10章 競爭格局

• Thermo Fisher Scientific
• Agilent Technologies
• Danaher Corporation
• PerkinElmer
• Merck KGaA
• Roche Holding AG
• QIAGEN
• Bruker Corporation
• Bio-Rad Laboratories
• Illumina
• Charles River Laboratories
• Evotec
• WuXi AppTec
• Schrodinger
• Abcam

第11章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第12章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Drug Discovery Platforms Market is estimated to be valued at USD 240.2 Mn in 2026 and is expected to reach USD 590.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 13.7% from 2026 to 2033.

The global drug discovery platforms market has witnessed significant growth in recent years, driven by the increasing demand for novel therapeutics and the need for more efficient drug discovery processes. Drug discovery platforms play a crucial role in the identification and development of new drug candidates, utilizing advanced technologies such as high-throughput screening, genomics, proteomics, and computational tools. These platforms enable researchers to streamline the drug discovery process, reduce costs, and accelerate the timeline from initial screening to clinical trials. The market encompasses various types of platforms, including biochemical assays, cell-based assays, in silico modeling, and fragment-based drug discovery. The adoption of drug discovery platforms has been further fueled by the growing prevalence of chronic diseases, the emergence of personalized medicine, and the increasing collaboration between pharmaceutical companies and academic institutions.

Market Dynamics:

The global drug discovery platforms market is driven by several factors, including the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the need for more efficient drug discovery processes. The rising prevalence of cancer, cardiovascular diseases, and neurological disorders has created a significant demand for novel therapeutics, propelling the growth of the drug discovery platforms market. Additionally, the shift towards personalized medicine has necessitated the development of targeted therapies, which rely heavily on drug discovery platforms for identifying specific molecular targets and optimizing drug candidates. However, the market growth is restrained by the high cost associated with drug discovery and development, as well as the stringent regulatory requirements for drug approval. Furthermore, the lack of skilled professionals and the complexity of integrating various technologies pose challenges to market growth. Despite these restraints, the market presents significant opportunities, such as the increasing adoption of artificial intelligence and machine learning in drug discovery, the growing focus on rare diseases, and the potential for collaborations between pharmaceutical companies and technology providers to develop innovative drug discovery solutions.

Key Features of the Study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global drug discovery platforms market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific, Agilent Technologies, Danaher Corporation, PerkinElmer, Merck KGaA, Roche Holding AG, QIAGEN, Bruker Corporation, Bio-Rad Laboratories, Illumina, Charles River Laboratories, Evotec, WuXi AppTec, Schrodinger, and Abcam
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global drug discovery platforms market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug discovery platforms market

Market Segmentation

• Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
• Small Molecule
• Large Molecule
• Technology Insights (Revenue, USD Mn, 2021 - 2033)
• Genomics
• Proteomics
• Cell-Based Assays
• High-Throughput Screening (HTS)
• Bioinformatics
• Next-Generation Sequencing (NGS)
• Mass Spectrometry
• Imaging Technologies
• Microfluidics
• Artificial Intelligence (AI) & Machine Learning (ML)
• Therapeutic Area Insights (Revenue, USD Mn, 2021 - 2033)
• Oncology
• Neurology
• Infectious And Immune System Diseases
• Digestive System Diseases
• Cardiovascular Diseases
• Diabetes
• Respiratory Disease
• Application Insights (Revenue, USD Mn, 2021 - 2033)
• Target Identification
• Target Validation
• Lead Discovery
• Lead Optimization
• Preclinical Testing
• Others (Clinical Trials, etc.)
• End User Insights (Revenue, USD Mn, 2021 - 2033)
• Biopharmaceutical Companies
• Academic and Research Institutes
• CROs/CDMOs
• Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Thermo Fisher Scientific
• Agilent Technologies
• Danaher Corporation
• PerkinElmer
• Merck KGaA
• Roche Holding AG
• QIAGEN
• Bruker Corporation
• Bio-Rad Laboratories
• Illumina
• Charles River Laboratories
• Evotec
• WuXi AppTec
• Schrodinger
• Abcam

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Drug Discovery Platforms Market, By Drug Type
  • Global Drug Discovery Platforms Market, By Technology
  • Global Drug Discovery Platforms Market, By Therapeutic Area
  • Global Drug Discovery Platforms Market, By Application
  • Global Drug Discovery Platforms Market, By End User
  • Global Drug Discovery Platforms Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Drug Discovery Platforms Market, By Drug Type, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Small Molecule
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Large Molecule
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

5. Global Drug Discovery Platforms Market, By Technology, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Genomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Proteomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Cell-Based Assays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• High-Throughput Screening (HTS)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Bioinformatics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Next-Generation Sequencing (NGS)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Mass Spectrometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Imaging Technologies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Microfluidics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Artificial Intelligence (AI) & Machine Learning (ML)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

6. Global Drug Discovery Platforms Market, By Therapeutic Area, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Infectious And Immune System Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Digestive System Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Respiratory Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

7. Global Drug Discovery Platforms Market, By Application, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Target Identification
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Target Validation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Lead Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Lead Optimization
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Preclinical Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Others (Clinical Trials, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

8. Global Drug Discovery Platforms Market, By End User, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• CROs/CDMOs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

9. Global Drug Discovery Platforms Market, By Region, 2021 - 2033, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• PerkinElmer
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Roche Holding AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• QIAGEN
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bruker Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Illumina
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Charles River Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Evotec
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• WuXi AppTec
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Schrodinger
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abcam
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us